lamivudine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68999-706
  • Package NDC 68999-706-24
  • Application number ANDA203564
  • SPL ID 476c3997-b596-17d2-e063-6394a90a6ca1
  • SPL set ID b23aea53-324b-4ff2-8736-639e4045e388
  • UNII 2T8Q726O95
  • RxCUI 199148

What the source publishes

Labeler
Chartwell Govermental & Specialty RX, LLC.
Active ingredients
lamivudine oral
Form
SOLUTION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68999-706_476c3997-b596-17d2-e063-6394a90a6ca1
{
  "name": "lamivudine",
  "splId": "476c3997-b596-17d2-e063-6394a90a6ca1",
  "labels": [
    {
      "setId": "b23aea53-324b-4ff2-8736-639e4045e388",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b23aea53-324b-4ff2-8736-639e4045e388",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b23aea53-324b-4ff2-8736-639e4045e388"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Chartwell Govermental & Specialty RX, LLC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 TRAY in 1 BOX (68999-706-24)  / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30)",
      "package_ndc": "68999-706-24",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251224"
    }
  ],
  "productId": "68999-706_476c3997-b596-17d2-e063-6394a90a6ca1",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION",
  "productNdc": "68999-706",
  "deaSchedule": null,
  "genericName": "lamivudine oral",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LAMIVUDINE",
      "strength": "10 mg/mL"
    }
  ],
  "applicationNumber": "ANDA203564",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20141031",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175656",
      "N0000175462",
      "N0000009947"
    ],
    "unii": [
      "2T8Q726O95"
    ],
    "rxcui": [
      "199148"
    ],
    "spl_set_id": [
      "b23aea53-324b-4ff2-8736-639e4045e388"
    ],
    "pharm_class_epc": [
      "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
      "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Chartwell Govermental & Specialty RX, LLC."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68999-706_476c3997-b596-17d2-e063-6394a90a6ca1"